Prevalence of Hepatitis C Virus Infection and Its Risk Factors among Patients Attending Rwanda Military Hospital, Rwanda

Table 6

Prevalence of haematological abnormalities among HCV infected participants.

Abnormality	(%)	Gender		-value	Age (yrs)			value
		Male	Female		18–35	36–55	>55
Leukopenia	15 (48.4%)	7 (53.8%)	8 (44.4%)	0.605	3 (75%)	2 (25%)	10 (52.6%)	0.221
Lymphopenia	1 (3.2%)	1 (7.7%)	0 (%)	0.403	0	0	1 (5.3%)	0.853
Neutropaenia	2 (6.5%)	1 (7.7%)	1 (5.6%)	0.332	1 (25%)	0	1 (5.3%)	0.296
Thrombocytopenia	8 (25.8%)	2 (15.4%)	6 (33.3%)	0.260	0	0	8 (42.1%)	0.033
Anaemia	1 (3.2%)	0 (0%)	1 (5.6%)	0.388	0	0	1 (5.3%)	0.722
ESR	5 (16.1%)	3 (23.1%)	2 (11.1%)	0.537	0	2 (25%)	3 (15.8%)	0.539

Significant at 95% confidence interval. Computed using Chi-square test. Reference range of hematological variables: total WBC count (4.50–11.50 [10³/μL]) lymphocytes (Female: 1.30–3.70, males: 1.20–4.80 [10³/µL]); neutrophils (Females: 1.10–4.40, males: 2.30–8.10 [10³/µL]); platelets (150–540 [10³/µL]), haemoglobin (Females: 11.0–17.0, Males: 12.0–18.0 [g/dL]), and ESR (<20 mm/hr).